Cargando…
Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model
Caffeine elicits protective effects against liver diseases, such as NASH; however, its mechanism of action involving the pyrin domain-containing-3 (NLRP3) inflammasome signaling pathway remains to be elucidated. This study aimed to evaluate the effect of caffeine on the NLRP3 inflammasome signaling...
Autores principales: | Vargas-Pozada, Eduardo E., Ramos-Tovar, Erika, Rodriguez-Callejas, Juan D., Cardoso-Lezama, Irina, Galindo-Gómez, Silvia, Talamás-Lara, Daniel, Vásquez-Garzón, Verónica Rocío, Arellanes-Robledo, Jaime, Tsutsumi, Víctor, Villa-Treviño, Saúl, Muriel, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456282/ https://www.ncbi.nlm.nih.gov/pubmed/36077357 http://dx.doi.org/10.3390/ijms23179954 |
Ejemplares similares
-
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
por: Wan, Xingyong, et al.
Publicado: (2016) -
Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH
por: Ioannou, George N., et al.
Publicado: (2023) -
Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase
por: Shi, Wei, et al.
Publicado: (2023) -
Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies
por: Idelfonso-García, Osiris Germán, et al.
Publicado: (2022) -
Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine
por: Fan, Frank S.
Publicado: (2022)